Raymond James on Thursday downgraded Ares Capital (NASDAQ:ARCC) shares to Market Perform from Outperform in what analyst Robert Dodd called a "valuation driven rationale, not a credit/portfolio issue.

Medexus Pharmaceuticals reported a strong performance in its Q3 FY2025 earnings call, with notable revenue growth and strategic advancements. The company highlighted a year-over-year increase in ...

There is a growing, untapped opportunity today to invest in tremendous American lower middle market businesses – the true engine of our economy – that are underserved by the capital markets,” said ...

“BTC's resilience above $90k is impressive, but we remain cautious about negative geopolitical shocks from U.S.-China ...

Family enterprises must balance legacy and professionalization to sustain wealth. Adapting asset management strategies can ...

The U.S. Agency for International Development (USAID) not only disbursed $44 billion in fiscal 2023, but anchors private ...

Saudi Aramco, the world's largest oil company, on Thursday said it had significantly raised the price of physical crude for Asian buyers. Aramco raised the March price of its flagship Arab light crude ...

BMO Capital raised the firm’s price target on Cognizant (CTSH) to $94 from $88 but keeps a Market Perform rating on the shares. The company ...

A type of risky debt that has taken US capital markets by storm in the past year is now emerging in bonds designed to unlock hundreds of billions in lending for the world’s poorest.

The aggregate CLO market outperformed the AAA-only subset by 73 basis points per year over the past five years. Click to read ...

I expect to see a dynamic resurgence in M&A activity within the franchising industry, with several key sectors driving this growth.